English 中文版
Clinical Center
Medical Oncology
Surgery
Gynecologic Oncology
Traditional Chinese Medicine/Integrative Oncology
Radiation Oncology
Anesthesiology
Medical Laboratory

Contact Us

Tel: +86-731-88651900

Fax: +86-731-88651999

Mail: hnszlyy_network@163.com

Add: 283 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, P.R. China

Doctor Profile Home > Departments > MEDICAL ONCOLOGY > Breast Internal Medicine Department

Dr. OUYANG Quchang
Breast Internal Medicine Department, Professor & Director
  • Education & Professional Experiences:

    1987-1992 studied undergraduate courses in the Medical Department of Hunan Medical University

    1992-1995 worked in the Medical Department of Hunan Cancer Hospital 

    1995-1998 studied postgraduate courses in Xiangya School of Medicine of the Central South University  

    1998-2001 worked in the Medical Department of Hunan Cancer Hospital 

    2001-2005 studied doctorate courses in Xiangya School of Medicine of the Central South University while working in Medical Department of Hunan Cancer Hospital

    2005-2009 worked in Medical Department and Medical Administration Department of Hunan Cancer Hospital 

    2009-now, working in the Medical Department of Hunan Cancer Hospital  


  • Specialty:

    Dr. Ouyang specializes in preventing breast cancer and diagnosing and treatment breast cancer of different stages.

  • Research:

    Subjects of Hunan Provincial S&T Department and the Provincial Health Department. 

  • Publications:

    1. Study on Correlation Between Expressions of ER, PR, Ki67, HER-2 and the Effect of Neoadjuvant Chemotherapy in Breast Cancer. Chinese Journal of Clinical Oncology and Rehabilitation, Vol 18, Issue 5, 2011, Corresponding Author. 



    2. Function and Mechanism of Dexrazoxane Interventing Myocardial Damage Induced by Epirubicin in Rats. Chinese Journal of Cancer Prevention and Treatment, Issue 19 of 2013, Corresponding Author. 



    3.Expression and Clinicopathological Significance of Angiopoietin-2 and α5β1 Integrin in the Breast Cancer. Progress of Modern Biomedicine, July 30, 2013, Corresponding Author 


    4.The Val158Met Polymorphism in the COMT Gene is Associated with Increased Cancer Risks in Chinese Population. Tumor Biol, December 5, 2012, Corresponding Author

         


    5. Some Issues on Local Treatment of the Primary Tumor in Breast Cancer Patients with Stage IV Disease. Medicine and Philosophy, Vol 35, Issue 9B, September 2014. The First Author    


    6.Clinical Observation of Treating Recurrent and Metastatic Breast Cancer by Regimens Containing Capecitabine. Chinese Journal of Clinical Oncology and Rehabilitation, June 20, 2012, the 2nd Author.  



    Works: New Conception and Clinical Strategy of Modern Whole-Course Management of Breast Cancer 


  • Awards:

    Member of the CSCO Youth Experts Committee, councilor of Hunan Anti-cancer Association, Deputy Chairman of the Professional Committee of Tumor Chemotherapy of Hunan Anti-cancer Association, Deputy Chairman of the Professional Committee of Tumor Chemotherapy of Hunan Medical Association, Deputy Chairman of the Professional Committee of Cancerous Rehabilitation and Palliative Treatment of Hunan Medical Association, leader of the Academic Group of Breast Cancer of the Professional Committee of Tumor Chemotherapy of Hunan Medical Association.

  • Out-patient Schedule:

    Monday

  • E-mail:

    Oyqc1969@126.com

Related
News
Newsroom
Notice
Videos
International
Clinical Service
Departments
Find a Doctor
Experts
Request an Appointment
Research & Education
Cancer Research
Clinical Trials
Selected Publications
Graduate Education
Resident Training
Download Center
Nursing
Nursing
About us
Introduction
Leadership
Contact
Q&A